The Centre’s Annual Symposium is the physical manifestation of the wealth of excellence we have here in Oxford and the passion and commitment to cancer research that is shared across our community. The programmes showcase the breadth of activity across the Centre and often feature cross-departmental or interdisciplinary partnerships supporting translational cancer research in Oxford.
The Symposium provides an opportunity for our members to network and often sparks new opportunities for partnership. It is also provides a platform to highlight our younger scientists through poster competitions and presentations from Centre-funded students.
Registration is now open for the CRUK Oxford Centre’s 9th Annual Symposium. It will take place virtually on Wednesday 21st October 2020.
This year’s event will be different – we unfortunately cannot host our event as planned due to COVID-19 pandemic. As a result, we are not able to showcase a poster competition and abstracts will not be submitted.
However, we will be hosting a 1 day online event, which will include:
- themed talks ranging from Non-Genetic Heterogeneity to Early Detection
- a New to Oxford session, featuring new Oxford cancer researchers and insights into where Oxford research may be going
- a special talk by our Keynote Prof. zur Hausen
Details of the full programme is currently being confirmed – please keep an eye on our Eventbrite page or this page for further updates
**UPDATE** 12 Aug 2020
More speakers and the official programme will be announced in the coming weeks.
Registration is free. Sign up here
Please note that registration is only open to Centre members. (Please use this link to become a Centre member.)
If you have any questions regarding the Symposium please contact the Centre: email@example.com
2015 Symposium – 5th June, Mathematical Institute
Thank you to all the CRUK Oxford Centre members that attended the Symposium on Friday 5th June.
We were delighted to welcome back a CRUK Oxford Centre funded DPhil student, Johanna Rankin (Prof Sarah Darby, Clinical Trials Service Unit), and Clinical Research Training Fellow, Kezia Gaitskell (Prof V. Beral & Prof A. Ahmed, Cancer Epidemiology Unit / Nuffield Department of Obstetrics & Gynaecology), to give prize talks. The Centre is proud of the achievements of these students and we were thrilled to welcome some of the brightest and best at the symposium this year. The post-doc prize talk was given by David Clynes (Prof R. Gibbons & Prof D. Higgs Lab, Weatherall Institute of Molecular Medicine), who was chosen to present his work on supression of the alternative lengthening of telomere pathway by the chromatin remodeling factor ATRX.
A number of collaborative showcases illustrated the successes that come from interdisciplinary work, and we also welcomed some new Centre members to the stage to share the skills they have bought to Oxford. The Centre was thrilled to have Professor Sir David Lane at the Symposium to deliver the keynote lecture. David described the generation and identification of point mutation specific antibodies as well as antibodies that mimic the T cell receptor by recognizing the neoantigen peptide MHC complex as the concept of cryptic epitopes . He also reviewed the recent data that suggests that intracellular antigens may also be viable targets for immune therapy approaches.
We’d like to thank all those who submitted abstracts and presented their posters at the Symposium. It was a brilliant opportunity for all attendees to find out about the world-leading science taking place here in Oxford. Congratulations to the Centre members who were awarded the poster prizes by the judging panel. The judges were especially impressed by the scientific content of the posters, the knowledge of the presenters, and the way the data had been displayed.
The posters selected for the CRUK Oxford Centre 2015 Poster Prizes are:
- Polymorphisms in the P53 pathway are enriched in Cancer Susceptibility Loci and share Charactertistics with Somatic Pathway Mutations – Giovanni Stracquadanio, Bond Lab, Ludwig Institute for Cancer Research
- Dose-escalated radiotherapy for NSCLC: heart dose versus survival in IDEAL-CRT – Sindu Vivekanandan, Hawkins / Fenwick Lab, CRUK / MRC Oxford Institute for Radiation Oncology
- The role of exosome signalling in the development and progression of prostate cancer – Kristie McCormick, Goberdhan Lab, Department of Physiology, Anatomy and Genetics
If you attended the Symposium and would like to find out any more information about any of the presentations you saw, any of the posters, or further information on the CRUK Oxford Centre then please contact firstname.lastname@example.org